
Customize View
Recently disclosed strategic alliances only (within the last two years)
Include Strategic Alliances for:Current subsidiaries



Strategic Alliances

Recently Disclosed Strategic Alliances
Strategic Alliance Name
Company Name
Primary Industry
Source
A&T Corporation
Abbott Laboratories (NYSE:ABT)
Health Care Equipment
A&T Corporation - Form 
Business Description: A&T Corporation develops, manufactures, and markets products in the fields of chemicals, analyzers, computers, and lab-logistics in Japan and internationally. It offers laboratory automation systems and managed pre-analysis modules; coagulation, electrolyte, and glucose analyzers; reagents for immunoassays; and CLINILAN, a laboratory resource planning system. The company was founded in 1978 and is headquartered in Yokohama, Japan. As of February 1, 2021, A&T Corporation operates as a subsidiary of Tokuyama Corporation.
A&T Corporation
Jinsung Meditech Inc.
Health Care Equipment
A&T Corporation - Form 
Business Description: A&T Corporation develops, manufactures, and markets products in the fields of chemicals, analyzers, computers, and lab-logistics in Japan and internationally. It offers laboratory automation systems and managed pre-analysis modules; coagulation, electrolyte, and glucose analyzers; reagents for immunoassays; and CLINILAN, a laboratory resource planning system. The company was founded in 1978 and is headquartered in Yokohama, Japan. As of February 1, 2021, A&T Corporation operates as a subsidiary of Tokuyama Corporation.
Aetna Inc.
Abbott Laboratories (NYSE:ABT)
Managed Health Care
Key DevelopmentClient Announcements Sep-04-2018
Business Description: Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers’ compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products comprising pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut. Aetna Inc. operates as a subsidiary of CVS Pharmacy, Inc.
Alibaba Health Information Technology Limited (SEHK:241)
Abbott Laboratories (NYSE:ABT)
Drug Retail
Alibaba Health Information Technology Limited (SEHK:241) 2020 Form Doc
Business Description: Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical direct sales, pharmaceutical e-commerce platform, and healthcare and digital services businesses in Mainland China and Hong Kong. It offers range of prescription drugs, over-the-counter drugs, nutritional supplements, medical devices, contact lenses, and various other health-related products through its online stores on Tmall.com and offline pharmacy outlets to business-to-customer and business-to-business customers; and pharmaceutical products, medical devices and healthcare products, health food, adult and family planning products, contact lenses, and medical and healthcare services through its e-commerce platform. The company also provides medical and healthcare services, including medical checkups, nucleic acid testing, medical consultation, registration, vaccination, and traditional Chinese medicine through various channels, such as Taobao, Tmall, Alipay, Dr. Deer APP, AMap, Freshippo, DingTalk, and Quark. In addition, it engages in the digital tracking business; provision of network hospital, healthcare related internet information, internet information, and healthcare related technical services; operation of internet hospitals; and asset management services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. Alibaba Health Information Technology Limited was incorporated in 1998 and is based in Causeway Bay, Hong Kong.
American Diabetes Association, Inc.
Abbott Laboratories (NYSE:ABT)
Health Care Services
Key DevelopmentStrategic Alliances Nov-09-2021
Business Description: American Diabetes Association, Inc. is a non profitable healthcare organization. The company provides research based advisory services focusing on diabetes and its treatment. It also conducts programs and publishes findings. American Diabetes Association, Inc. was founded in 1940 and is based in Alexandria, Virginia with an additional office in Maitland, Florida.
ANGLE plc (AIM:AGL)
Abbott Laboratories (NYSE:ABT)
Health Care Equipment
ANGLE plc (AIM:AGL) - Form Doc
Business Description: ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD. ANGLE plc has a partnership agreement with Bio View Ltd to develop a liquid biopsy circulating tumor cell HER2 assay for breast cancer. The company was founded in 1994 and is based in Guildford, the United Kingdom.
BG Medicine, Inc. (OTCPK:BGMD)
Alere Inc.
Life Sciences Tools and Services
BG Medicine, Inc. (OTCPK:BGMD) 2014 Form 10-K
Business Description: BG Medicine, Inc. engages in the development and commercialization of diagnostic products used to guide the patients suffering from heart failure and related disorders in the United States. The company offers BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke. It has license, development, and commercialization agreements with Abbott Laboratories, bioMérieux SA, Siemens Healthcare Diagnostics Inc., and Alere Inc. for the automated instrument versions of galectin-3 test; and a strategic collaboration with Abbott Laboratories to develop and commercialize galectin-3 assay kits, and related control kits and calibrators. The company was formerly known as Beyond Genomics, Inc. and changed its name to BG Medicine, Inc. in October 2004. BG Medicine, Inc. was founded in 2000 and is headquartered in Waltham, Massachusetts.
Cardinal Health, Inc. (NYSE:CAH)
Abbott Laboratories (NYSE:ABT)
Health Care Distributors
Key DevelopmentClient Announcements Aug-10-2021
Business Description: Cardinal Health, Inc. operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Cereno Scientific AB (publ) (OM:CRNO B)
Abbott Laboratories (NYSE:ABT)
Biotechnology
Key DevelopmentStrategic Alliances Aug-11-2021
Business Description: Cereno Scientific AB (publ), clinical stage biotech company, develops therapeutics to treat cardiovascular and rare diseases through epigenetic modulation worldwide. Its lead drug candidate is CS1, a product candidate that is in Phase II clinical trial for the treatment of rare disease pulmonary arterial hypertension and thrombotic indications. It is also involved in developing histone deacetylase inhibitor that is in the preclinical stage for the treatment of cardiovascular diseases. The company has a collaboration agreement with the University of Michigan for the preclinical development program of CS585, a new drug candidate for cardiovascular diseases; and Abbott with for use of CardioMEMS HF System in upcoming Phase II study with the company’s CS1 drug candidate. Cereno Scientific AB (publ) was founded in 2012 and is headquartered in Mölndal, Sweden.
Cheil Worldwide Inc. (KOSE:A030000)
Abbott Laboratories (NYSE:ABT)
Advertising
Cheil Worldwide Inc. (KOSE:A030000) - Form 
Business Description: Cheil Worldwide Inc. provides various marketing solutions worldwide. It offers strategic, creative, and media solutions; integrated digital marketing solution and social media platform; and experiential marketing solutions, such as events, exhibitions, sports, and retail marketing solutions. The company was founded in 1973 and is headquartered in Seoul, South Korea.
ChemDiv Research Institute
Abbott Products Limited Liability Company

Key DevelopmentStrategic Alliances Jul-09-2012
Business Description: There is no business description for this company.
Federation of Obstetric & Gynaecological Societies of India
Abbott India Limited (BSE:500488)
Diversified Support Services
Abbott India Limited (BSE:500488) - Form Doc
Business Description: There is no business description for this company.
Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882)
Abbott Laboratories (NYSE:ABT)
Health Care Services
Guangzhou Kingmed Diagnostics Group Co., Ltd. (SHSE:603882) - Form 
Business Description: Guangzhou Kingmed Diagnostics Group Co., Ltd. provides medical diagnosis services in China. The company also offers clinical research, health management, cold chain logistics, and scientific research services, as well as vitro diagnostics, big data, artificial intelligence, and forensic testing services. Guangzhou Kingmed Diagnostics Group Co., Ltd. was founded in 2006 and is headquartered in Guangzhou, China.
Insigma Technology Co., Ltd. (SHSE:600797)
Abbott Laboratories (NYSE:ABT)
IT Consulting and Other Services
Insigma Technology Co., Ltd. (SHSE:600797) - Form 
Business Description: Insigma Technology Co., Ltd. operates as an information technology consulting and service company in China. It offers digital cloud services, government digitalization, infrastructure digitalization, and industrial digitalization solutions. The company also provides IDC hosting, Internet resource acceleration, and cloud computing services; and social insurance management province concentration, smart medical insurance management and services system, employment management and service information system, wage supervision system for migrant workers, labor relationship operation management platform, big data analysis and service platform, mobile medical payment, and other solutions; social security fund security online & smart platform for human resources and social security monitoring; Zhejiang Enterprise Online, a government-enterprise interaction platform; digital smart municipal platform & smart urban management platform; and airport integrated management platform & smart bridge safety monitoring solutions. In addition, it offers artificial intelligence business analysis platform, financial data service platform, and domestic financial market series products, such as quotation engine system, foreign exchange market maker system, foreign exchange capital trading system, village bank credit system, comprehensive market analysis system , financial component rapid development framework, intelligent investment advisory, and intelligent payment accounting, as well as application development, testing and quality assurance, user experience design, system reconstruction, IT operation and maintenance, high-end consulting, research and development, and other comprehensive professional technical services. The company was formerly known as Zhejiang Natural Technology Co. Ltd. and changed its name to Insigma Technology Co., Ltd. in 2001. Insigma Technology Co., Ltd. was founded in 1994 and is headquartered in Hangzhou, China.
JW Holdings Corporation (KOSE:A096760)
Abbott Laboratories (NYSE:ABT)
Pharmaceuticals
JW Holdings Corporation (KOSE:A096760) - Form 
Business Description: JW Holdings Corporation, together with its subsidiaries, manufactures and sells medicines and medical devices in South Korea and internationally. It offers ETC products, consumer healthcare OTC products, and IV solutions machinery systems. The company also exports its products. JW Holdings Corporation was founded in 1945 and is based in Seoul, South Korea.
MINAPHARM Pharmaceuticals (CASE:MIPH)
Abbott Laboratories (NYSE:ABT)
Pharmaceuticals
MINAPHARM Pharmaceuticals (CASE:MIPH) - Form 
Business Description: MINAPHARM Pharmaceuticals operates as a pharmaceutical company primarily in Egypt and the Middle East. The company’s products include Angiofox capsules, Artelac and Berberil eye drops; Bon-one, Ciprodiazole, Dumozol, Hydroquine, and Burinex tablets; Chlorhexidine; DICYNONE; Corneregel fluid and ophthalmic gel; Betolvex and Fleboton ampoules; Deponit patches; Dexagel viscous eye drops; Doxiproct plus and Doxiproct ointment; Doxium capules; Broncho-Vaxom capsules for adults and infants; Broncho-Vaxom infant sachets; Netophtiole plus eye drops; Extrauma cream; and Ophtatrov and Optatrov plus. It also provides Ferroduonal, Lipanthyl, Parafon, Ribavirin, Uro-Vaxom, Ursofalk, Ursoplus, Ursotwin, and Ferro Sanol Gyn capsules; Gyno-Pevaryl, Pevisone, Srilane, and Pevaryl cream; Gonapure; Hair Plus Back 2% and 5%; Hair Plus Back Topical FOAM; Lucidril 500; Lucidril, Salofalk, Trimed flu, XerovirinC, Pixcolt, and Ossopan tablets; Thrombexx ampoules, cream, and gel; Vidisept N drops; and Luciforte, Oxytocin, Reiferon Retard, and Nausilex ampoules. The company offers its products for the treatment of hematoma and thrombosis, iron deficiency anemia, recurrent urinarytract infections, immunostimulants, osteoporosis, renal osteodystrophy, loop diuretics, prophylaxis, hemorrhoids, rheumatoid arthritis, hyperlipidemia, alopecia, skin infections, topical corticosteroids, gynecological antifungals, vaginal infections, anti-infective, dyslipidemia, muscle spasm, dry eye, eye inflammation and allergy, corneal, nausea and vomiting, hepatology and gastroenterology, coronary heart, respiratory tract infections, occular irritation, labour induction, cerebral insufficiency, surgical dressing, prophylaxis, pregnancy and lactation, hemostasis, hemorrhage, infertility, and microvascular diseases, as well as vitamin B12 deficiency, anemia, and diabetic neuropathy. The company was founded in 1958 and is headquartered in Cairo, Egypt.
Samil Pharmaceutical Co.,Ltd (KOSE:A000520)
Abbott Laboratories (NYSE:ABT)
Pharmaceuticals
Samil Pharmaceutical Co.,Ltd (KOSE:A000520) - Form 
Business Description: Samil Pharmaceutical Co.,Ltd engages in the manufacture and sale of indispensable medicines in South Korea. It offers hepatic, gastrointestinal, vasodilator, antithrombotic, respiratory, skeletal muscle relaxants, circulatory, neurological, antibiotics, metabolic, antihistamines, immunosuppressive, hormone, anti-tumor, urinary, and ophthalmic drugs, as well as antipyretic, analgesic, and anti-inflammatory agents. The company also provides OTC products and sanitary aids. Samil Pharmaceutical Co.,Ltd was founded in 1947 and is headquartered in Seoul, South Korea.
Sanofi (ENXTPA:SAN)
Abbott Laboratories (NYSE:ABT)
Pharmaceuticals
Sanofi (ENXTPA:SAN) 2021 Form 20-F
Business Description: Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Saudi Printing and Packaging Co. (SASE:4270)
Abbott Laboratories (NYSE:ABT)
Commercial Printing
Saudi Printing and Packaging Co. (SASE:4270) - Form 
Business Description: Saudi Printing and Packaging Co. provides printing services in the Kingdom of Saudi Arabia, the Middle East, and Northern Africa. It operates through Printing and Packaging segments. The company engages in printing newspapers, magazines, and books; and printing on plastics and commercial labels. It also manufactures and sells paper and plastic cups; bottles and closures; and plastic products and packaging materials. The company was formerly known as Al Madina Printing and Publishing Company and changed its name to Saudi Printing and Packaging Co. in 2007. Saudi Printing and Packaging Co. was founded in 1963 and is headquartered in Riyadh, the Kingdom of Saudi Arabia.
Société des Industries Pharmaceutiques de Tunisie - S.A. (BVMT:SIPHA)
Abbott Laboratories (NYSE:ABT)
Pharmaceuticals
Société des Industries Pharmaceutiques de Tunisie - S.A. (BVMT:SIPHA) - Form 
Business Description: Société des Industries Pharmaceutiques de Tunisie - S.A. engages in the research, development, manufacture, packaging, and marketing of pharmaceutical products for human use in Tunisia and internationally. The company offers products in the areas of allergology, analgesics, anesthesia, antihypertensive, antispasmodics, cardiology and angiology, cardiovascular system, dermatology, gastroenterology, hepatology, infectiology, metabolism and nutrition, neurology, pneumology, rheumatology, and stomatology, as well as anti-inflammatory drugs. It produces drugs of various galenic formulations in the form of tablets, capsules, sachets, tubes, suppositories, drinkable phials, perfusable bags, flasks, litters of concentrated solutions, perfusable solution bottles, and injectable ampoules. Société des Industries Pharmaceutiques de Tunisie - S.A. was founded in 1970 and is headquartered in Ben Arous, Tunisia.
Sunshine Holdings PLC (COSE:SUN.N0000)
Abbott Laboratories (NYSE:ABT)
Agricultural Products and Services
Sunshine Holdings PLC (COSE:SUN.N0000) 2020 Form Doc
Business Description: Sunshine Holdings PLC, together with its subsidiaries, operates in the healthcare, agribusiness, and consumer goods businesses. It manufactures, imports, markets, distributes, and retails pharmaceuticals to retail pharmacies, modern trade, institutions, government tenders, and government-owned pharmacy chains in the areas of dermatological, diabetic, cardiovascular, gastrointestinal, and pain management drugs; distributes surgical and diagnostic equipment; and operates a network of 13 retail outlets that provide a range of health and wellness solutions. The company is also involved in the planation of oil palm, rubber, and cinnamon; and operation of a dairy farm. In addition, it produces tea under the Zesta, Watawala, and Ran Kahata brands; and toffees, jellies, chocolates, bubblegum, desserts, biscuits, and snacks under the Milady and Daintee brands. Sunshine Holdings PLC was founded in 1967 and is based in Colombo, Sri Lanka.
TSH Biopharm Corporation Limited (TPEX:8432)
Abbott Laboratories (NYSE:ABT)
Pharmaceuticals
TSH Biopharm Corporation Limited (TPEX:8432) - Form 
Business Description: TSH Biopharm Corporation Limited develops and markets medicines for chronic diseases in Taiwan. It offers products for cardiovascular, central nervous, gastrointestinal, and others, as well as liquid-biopsy diagnosis. The company is headquartered in Taipei city, Taiwan. TSH Biopharm Corporation Limited is a subsidiary of TTY Biopharm Company Limited.
U2Bio Co., Ltd. (XKON:A221800)
Abbott Korea Limited
Health Care Services
U2Bio Co., Ltd. (XKON:A221800) - Form 
Business Description: U2Bio CO. LTD. provides medical IT solutions in South Korea. The company also offers clinical pathology, anatomical pathology, molecular diagnostics, and various diagnostic tests, and others. The company was founded in 2009 and is headquartered in Seoul, South Korea.
United Airlines, Inc.
Abbott Laboratories (NYSE:ABT)
Passenger Airlines
Key DevelopmentClient Announcements May-12-2021
Business Description: United Airlines, Inc. operates in the airlines industry. The company was founded in 1931 and is based in Chicago, Illinois. United Airlines, Inc. operates as a subsidiary of United Airlines Holdings, Inc.
Whan In Pharm Co.,Ltd. (KOSE:A016580)
Abbott Laboratories (NYSE:ABT)
Pharmaceuticals
Whan In Pharm Co.,Ltd. (KOSE:A016580) - Form 
Business Description: Whan In Pharm Co.,Ltd., a pharmaceutical company, develops, manufactures, markets, and sells therapeutic products in South Korea. It offers anti-depressants, anti-psychotics, nootropics and anti-dementia, anti-epileptics, cardiovascular, gastrointestinal, antibiotics, antiviral agents, antihistamines, anti-inflammatory and analgesics, metabolic disorders, respiratory, central nervous system, other drug products. The company was founded in 1978 and is headquartered in Seoul, South Korea.
WW International, Inc. (NasdaqGS:WW)
Abbott Laboratories (NYSE:ABT)
Specialized Consumer Services
Key DevelopmentStrategic Alliances Aug-04-2022
Business Description: WW International, Inc. provides weight management products and services worldwide. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. The company also provides various digital subscription products to wellness and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program through its app and web-based platform, including personal coaching and digital products; and allows members to inspire and support each other by sharing their experiences with other people on weight loss and weight management journeys. In addition, it offers various consumer products, including bars, snacks, cookbooks, kitchen tools, and other products. Further, the company licenses its trademarks and other intellectual property in food, beverages, and other relevant consumer products and services, as well as provides publishing services. It offers products through e-commerce platforms and through partners. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1961 and is headquartered in New York, New York.
*denotes proprietary relationship